Literature DB >> 32647638

Reply to the Letter to the Editor: "Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma".

Clemens Schotten1, Heiner Wedemeyer1, Jan Best1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32647638      PMCID： PMC7325123          DOI： 10.1159/000506947

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  8 in total

1.  Propensity scores: help or hype?

Authors:  Wolfgang C Winkelmayer; Tobias Kurth
Journal:  Nephrol Dial Transplant       Date:  2004-04-06       Impact factor: 5.992

2.  Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma.

Authors:  Nicolas Williet; Léa Clavel; Aurélie Bourmaud; Céline Verot; Nadia Bouarioua; Xavier Roblin; Philippe Merle; Jean-Marc Phelip
Journal:  Dig Liver Dis       Date:  2017-06-23       Impact factor: 4.088

Review 3.  Propensity Score: an Alternative Method of Analyzing Treatment Effects.

Authors:  Oliver Kuss; Maria Blettner; Jochen Börgermann
Journal:  Dtsch Arztebl Int       Date:  2016-09-05       Impact factor: 5.594

4.  More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.

Authors:  Tomi W Jun; Ming-Lun Yeh; Ju Dong Yang; Vincent L Chen; Pauline Nguyen; Nasra H Giama; Chung-Feng Huang; Ann W Hsing; Chia-Yen Dai; Jee-Fu Huang; Wan-Long Chuang; Lewis R Roberts; Ming-Lung Yu; Mindie H Nguyen
Journal:  Liver Int       Date:  2017-11-03       Impact factor: 5.828

5.  Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.

Authors:  Arndt Weinmann; Yvonne Alt; Sandra Koch; Carina Nelles; Christoph Düber; Hauke Lang; Gerd Otto; Tim Zimmermann; Jens U Marquardt; Peter R Galle; Marcus A Wörns; Jörn M Schattenberg
Journal:  BMC Cancer       Date:  2015-04-01       Impact factor: 4.430

Review 6.  Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances.

Authors:  M Sanni Ali; Daniel Prieto-Alhambra; Luciane Cruz Lopes; Dandara Ramos; Nivea Bispo; Maria Y Ichihara; Julia M Pescarini; Elizabeth Williamson; Rosemeire L Fiaccone; Mauricio L Barreto; Liam Smeeth
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

7.  NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.

Authors:  Clemens Schotten; Lars P Bechmann; Paul Manka; Jens Theysohn; Alexander Dechêne; Amr El Fouly; Francesco Barbato; Ursula Neumann; Sonia Radünz; Svenja Sydor; Dominik Heider; Marino Venerito; Ali Canbay; Guido Gerken; Ken Herrmann; Heiner Wedemeyer; Jan Best
Journal:  Liver Cancer       Date:  2019-07-29       Impact factor: 11.740

8.  Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults.

Authors:  Hui Guo; Tao Wu; Qiang Lu; Jian Dong; Yi-Fan Ren; Ke-Jun Nan; Yi Lv; Xu-Feng Zhang
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.